There are 203 resources available
Panel discussion
Session: Fast tracking drug development by early screening for tumour-agnostic potential: Trialist, sponsor and regulator views
Resources:
Webcast
Q&A and discussion
Session: Radiotheranostics
Resources:
Webcast
New conjugates for new targets: ADCs, ISACS, and others
Presenter: Barbara Pistilli
Session: New drugs for new targets
Resources:
Slides
Webcast
Better trials, better drugs: Can AI help?
Presenter: Allan Jordan
Session: Artificial intelligence (AI) in drug development
Resources:
Slides
Webcast
YAP/TEAD inhibitors
Presenter: Anastasios Stathis
Session: New drugs for new targets
Resources:
Slides
Webcast
Big data and machine learning in drug discovery
Presenter: Bissan Al-Lazikani
Session: Artificial intelligence (AI) in drug development
Resources:
Slides
Webcast
Digital pathology for biomarker discovery
Presenter: Anne Vincent-Salomon
Session: Artificial intelligence (AI) in drug development
Resources:
Slides
Webcast
Targeting MYC, targeting WNT, (...): What undruggables are left?
Presenter: Cinta Hierro Carbo
Session: New drugs for new targets
Resources:
Slides
Webcast
Drugs for new synthetic lethality scenarios: WRN and MTAP
Presenter: Jordi Rodon
Session: New drugs for new targets
Resources:
Slides
Webcast
AI in oncology: Current clinical endeavors and future directions
Presenter: Jakob Nikolas Kather
Session: Artificial intelligence (AI) in drug development
Resources:
Slides
Webcast